Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.
about
Recurrence after operative management of intrahepatic cholangiocarcinomaDiagnosis of incidental gallbladder cancer after laparoscopic cholecystectomy: our experienceImplications of the index cholecystectomy and timing of referral for radical resection of advanced incidental gallbladder cancerPrediction of the lymph node status in patients with intrahepatic cholangiocarcinoma: analysis of 320 surgical cases.Expression and Significance of COX-2 and Ki-67 in Hepatolithiasis with Bile Duct Carcinoma.Outcomes after Resection of Intrahepatic Cholangiocarcinoma: External Validation and Comparison of Prognostic Models.Preoperative serum CA 19-9 level as a predictive factor for recurrence after curative resection in biliary tract cancer.Impact of Morphological Status on Long-Term Outcome Among Patients Undergoing Liver Surgery for Intrahepatic Cholangiocarcinoma.Prognostic Impact of the Initial Postoperative CA19-9 Level in Patients with Extrahepatic Bile Duct Cancer.Defining Long-Term Survivors Following Resection of Intrahepatic Cholangiocarcinoma.Prognostic value of CA 19-9 kinetics during gemcitabine-based chemotherapy in patients with advanced cholangiocarcinoma.Imaging of a patient with multiple intrahepatic cysts.Elevated perioperative serum CA 19-9 levels are independent predictors of poor survival in patients with resectable cholangiocarcinoma.The impact of perioperative CA19-9 change on the survival and recurrence patterns after adjuvant chemoradiotherapy in resectable extrahepatic cholangiocarcinoma.
P2860
Q30412886-E73BAD8B-6AA6-42D5-BF39-31D6B54BF449Q35051562-317EAFD7-1E30-446B-B98D-32F1EEAEFD6BQ35758233-A6BEFECD-9CC7-4B94-9BDF-0934DCCD40D6Q35971464-EB66A9BE-866F-4BF7-A090-299A48B7B669Q36131305-5EDB9B71-404F-478B-9B38-0CACF8222C46Q36667840-2FD8AAE8-8D28-4E8C-9DFC-E73C19835FDCQ37826379-4DD8B9D2-DDB9-464B-8337-5C4BC6519573Q38807638-92E3EEB8-773E-46A9-BEB1-166F140FD3FCQ39717600-557E88A0-9126-455F-B737-4184517E502AQ40499240-B61EAE23-2698-426A-A096-C221C56987D8Q41536189-8FD5AFA8-F824-424B-A04E-BC5FE6814F25Q41983591-DE81377E-4465-46BD-9259-5703A5406270Q45281931-DE1DA9E1-EDB0-4CE6-A4F2-2EADE42F8B9CQ48305693-B9A15C86-A342-4CF3-AC13-DE3F0766282B
P2860
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մարտին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@ast
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@en
type
label
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@ast
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@en
prefLabel
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@ast
Elevated CA 19-9 portends poor ...... ction of biliary malignancies.
@en
P2093
P2860
P1476
Elevated CA 19-9 portends poor ...... ection of biliary malignancies
@en
P2093
Carl Schmidt
E Christopher Ellison
Ioannis Hatzaras
Mark Bloomston
W Scott Melvin
P2860
P304
P356
10.1111/J.1477-2574.2009.00149.X
P577
2010-03-01T00:00:00Z